Tamadol Wound Infiltration in Children Under Inguinal Hernioplasty
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01943760 |
Recruitment Status :
Completed
First Posted : September 17, 2013
Last Update Posted : September 17, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Tramadol is a centrally acting analgesic, is primarily Indicated for the treatment of acute pain, moderate to severe. The hernioplasty in children is an outpatient procedure, and the possibility of postoperative analgesia with fewer systemic adverse effects such as nausea and vomiting make the tramadol infiltration a technique of interest. There is controversy about its effectiveness.
The local effect of tramadol in hernioplasty was also studied by researchers with some better postoperative analgesia than with local anestetic .
There are few studies with administration of tramadol for hernioplasty, Which led to the interest in this study.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Children Inguinal Hernia | Drug: tramadol Drug: 0.9% saline | Phase 4 |
The primary objective of the study was to evaluate the analgesic effect of tramadol injected into the surgical incision in patients undergoing hernioplasty.
The study is a prospective, comparative, double covered. The distribution of patients in the groups was randomly drawn prior to starting the project and the groups were identified in envelopes numbered 1-40.
Criteria for inclusion and exclusion After approval by the Ethics Committee of UNIFESP and signature of consent by those responsible, and the term of assent by patients over six years, 40 children of both sexes will be evaluated, aged between 3 and 12 years who underwent hernioplasty.
Children with bleeding disorders, using analgesic or sensitivity to any drug will be excluded.
The patients will be randomly divided into one of two groups. Patients in group 1 will receive local infiltration with 2 mg / kg of tramadol diluted in 5 ml of 0.9% saline solution and 20ml of 0.9% saline solution intravenously at the end of the surgical procedure Patients in group 2 will receive 2 mg.kg-1 tramadol intravenously diluted in 20 ml of 0.9% saline solution and local infiltration with 5 mL of saline solution 0.9% at the end of the surgical procedure.
All patients will undergo general anesthesia, and will receive additional analgesia with dipyrone and morphine as needed in post operative period.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 40 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Triple (Participant, Care Provider, Investigator) |
Primary Purpose: | Treatment |
Official Title: | Evaluation of the Analgesic Effect of Tramadol Wound Infiltration in Children Under Inguinal Hernioplasty. A Double-blind, Randomized Study. |
Study Start Date : | September 2012 |
Actual Primary Completion Date : | September 2013 |
Actual Study Completion Date : | September 2013 |

Arm | Intervention/treatment |
---|---|
Active Comparator: tramadol wound infiltration
2 mg / kg of tramadol diluted in 5 ml of 0.9% saline solution wound infiltration 20ml of 0.9% saline solution intravenously
|
Drug: tramadol
The volume of the solution was adequate to maintain the concentration of 2% tramadol
Other Name: tramal Drug: 0.9% saline |
Experimental: tramadol intravenous administration
2 mg / kg of tramadol diluted 20ml of 0.9% saline solution intravenously 5 ml of 0.9% saline solution wound infiltration
|
Drug: tramadol
The volume of the solution was adequate to maintain the concentration of 2% tramadol
Other Name: tramal Drug: 0.9% saline |
- Pain intensity after wound infiltration with tramadol [ Time Frame: 1 month ]Faces scale

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 3 Years to 12 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- children of both sexes
- aged between 3 and 12 years
- underwent hernioplasty
Exclusion Criteria:
- children with bleeding disorders
- using analgesic
- sensitivity to any drug.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01943760
Brazil | |
São Paulo Hospital | |
São Paulo, Brazil, 04023062 |
Principal Investigator: | Ana LA Giraldes, MD | Federal University of São Paulo |
Publications:
Responsible Party: | Ana Laura Albertoni Giraldes, doctor, Federal University of São Paulo |
ClinicalTrials.gov Identifier: | NCT01943760 History of Changes |
Other Study ID Numbers: |
187177 |
First Posted: | September 17, 2013 Key Record Dates |
Last Update Posted: | September 17, 2013 |
Last Verified: | September 2013 |
Tramadol Children Hernioplasty Wound infiltration |
Hernia, Inguinal Hernia Pathological Conditions, Anatomical Hernia, Abdominal Tramadol Analgesics, Opioid |
Narcotics Central Nervous System Depressants Physiological Effects of Drugs Analgesics Sensory System Agents Peripheral Nervous System Agents |